Business Description
ASKA Pharmaceutical Holdings Co Ltd
ISIN : JP3119660003
Description
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.79 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 0.86 | |||||
| Interest Coverage | 165.61 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.86 | |||||
| Beneish M-Score | -2.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y Total Revenue Growth Rate | 4.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.72 | |||||
| 9-Day RSI | 54.95 | |||||
| 14-Day RSI | 51.06 | |||||
| 6-1 Month Momentum % | -18.79 | |||||
| 12-1 Month Momentum % | 16.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.82 | |||||
| Quick Ratio | 1.71 | |||||
| Cash Ratio | 0.74 | |||||
| Days Inventory | 225.22 | |||||
| Days Sales Outstanding | 95.92 | |||||
| Days Payable | 45.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.18 | |||||
| Dividend Payout Ratio | 0.25 | |||||
| Forward Dividend Yield % | 2.42 | |||||
| 5-Year Yield-on-Cost % | 2.18 | |||||
| Shareholder Yield % | 6.56 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.37 | |||||
| Operating Margin % | 10.68 | |||||
| Net Margin % | 9.4 | |||||
| FCF Margin % | 0.05 | |||||
| ROE % | 9.75 | |||||
| ROA % | 6.53 | |||||
| ROIC % | 7.87 | |||||
| ROC (Joel Greenblatt) % | 23.23 | |||||
| ROCE % | 11.08 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.79 | |||||
| Forward PE Ratio | 12.11 | |||||
| PE Ratio without NRI | 11.27 | |||||
| PS Ratio | 0.92 | |||||
| PB Ratio | 0.91 | |||||
| Price-to-Tangible-Book | 0.96 | |||||
| Price-to-Free-Cash-Flow | 1771.01 | |||||
| Price-to-Operating-Cash-Flow | 39.34 | |||||
| EV-to-EBIT | 6.73 | |||||
| EV-to-EBITDA | 5.92 | |||||
| EV-to-Revenue | 0.83 | |||||
| EV-to-FCF | 1591.25 | |||||
| Price-to-Graham-Number | 0.69 | |||||
| Price-to-Net-Current-Asset-Value | 2.06 | |||||
| Earnings Yield (Greenblatt) % | 14.86 | |||||
| FCF Yield % | 0.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ASKA Pharmaceutical Holdings Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 63,566 | ||
| EPS (TTM) (円) | 210.93 | ||
| Beta | 0.6 | ||
| Volatility % | 19.93 | ||
| 14-Day RSI | 51.06 | ||
| 14-Day ATR (円) | 33.82961 | ||
| 20-Day SMA (円) | 2041.15 | ||
| 12-1 Month Momentum % | 16.88 | ||
| 52-Week Range (円) | 1752 - 2720 | ||
| Shares Outstanding (Mil) | 28.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ASKA Pharmaceutical Holdings Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ASKA Pharmaceutical Holdings Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
ASKA Pharmaceutical Holdings Co Ltd Frequently Asked Questions
What is ASKA Pharmaceutical Holdings Co Ltd(TSE:4886)'s stock price today?
The current price of TSE:4886 is 円2065.00. The 52 week high of TSE:4886 is 円2720.00 and 52 week low is 円1752.00.
When is next earnings date of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886)?
The next earnings date of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) is .
Does ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) pay dividends? If so, how much?
The Dividend Yield %  of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) is 2.18% (As of Today), Highest Dividend Payout Ratio of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) was 0.25. The lowest was 0.11. And the median was 0.12. The  Forward Dividend Yield % of ASKA Pharmaceutical Holdings Co Ltd(TSE:4886) is 2.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers